To determine whether the extent of LN involvement in the breast cancer patients influenced the role of Ki-67 in survival rates, we compared these variables in patients with 1–3 positive lymph nodes (n = 262) to those of patients with more than 4 positive lymph nodes (n = 188). This evidence concerns the gene MKI67 and breast carcinoma.